Safety of Continuing CHemotherapy in Overt Left Ventricular Dysfunction Using Antibodies to HER-2
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Heart Failure|Breast Cancer
Interventions: DRUG: standard-of-care treatments for LV impairment
Sponsor: Population Health Research Institute